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Our study offers additional intermediate and long-term
data supporting the safety of EVAR in patients with ARAs
and supports the safety of ARA coverage in a contemporary
cohort of patients. There was no overall difference in 30-
day or 24-month survival between patients with and with-
out ARA coverage. There were no clinically significant
ARA-related endoleaks. ARA size, pre-existing renal insuf-
ficiency, or hypertension did not influence outcomes in this
series. In contrast to findings in previous reports, renal mass
is commonly lost, but renal function is maintained after
ARA coverage during EVAR. Routine surveillance contin-
ues to be important for this patient cohort to follow both
renal function and adequacy of aneurysm repair.
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Dr Jeffrey L. Ballard (Orange, Calif). Dr Greenberg and
colleagues ask the often considered question, “Can we get away
with it?” That is, what happens when one covers reasonably sized
accessory renal arteries during endovascular aneurysm repair? They
studied this consequence using outcomes such as change in eGFR,
antihypertensive medication requirements, and renal infarct vol-
ume and compared patients with ARAcoverage to those whose
ARAs were preserved. These measures would seem to be more
telling than the usual situation in open AAA repair, when small,
nonbleeding accessory or other aortic branch vessels are ligated
without trepidation and larger ones that back-bleed are reattached
because it just seems appropriate. If the creatinine doesn’t change
post-op, then we did the right thing!
As you heard, mean patient follow-up was 27 months, no
patient was lost to follow-up, and the average ARA diameter was
not insignificant at 3 mm. Although there was a significant differ-
ence in renal infarct size between covered and uncovered ARA
groups, there was no change in eGFR or antihypertensive medica-
tion requirements. Additionally, there were no persistent type II
endoleaks related to uncovered ARAs. Subgroup analysis of pa-nce in outcome when patients with covered ARAs were compared
o those with uncovered ARAs.
The take-home message of this tidy, well-analyzed, well-
ritten paper is that, in fact, we can get away with it. Some renal
ass with be sacrificed but renal function as measured will be
aintained despite ARA coverage during endograft repair of
AAs.
I have two questions for the authors:
. Did suprarenal fixation, which was performed in nearly 50% of
your study group, impact the rate or volume of renal infarct?
. How does aortic neck length factor into your decision pro-
cess? For instance, would you cover a 4-mm ARA that
supplies perfusion to 30-35% of the kidney to secure a better
seal zone, or will you protect renal mass and deploy distal to
the seemingly significant ARA and risk an incomplete prox-
imal seal?
Thank you for the opportunity to discuss this paper.
Dr Matthew W Mell. We would first like to thank Dr Ballard
or his careful review of our manuscript and for his comments and
uestions. Relating to suprarenal fixation, there was an equal distri-
ution of patients with and without suprarenal fixation in patients
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conclude that transrenal fixation had no influence on renal outcomes.
Dr Ballard raises an excellent question regarding the crux of
the accessory renal artery issue; namely, when does one compro-
mise renal volume versus proximal aortic seal? This compromise
was clearly operative in the findings reported since necks werendings reported support a more liberal approach to ARA cover-
ge, these must be mitigated by individual patient physiology and
natomy. For instance, it might be appropriate to sacrifice a signif-
cant volume of one kidney in a patient who is too high risk for
pen surgery. Regardless of the decision made, we hope that our
esults at least serve to inform the patient when a strategy involvingshorter in patients requiring ARA coverage (P  .03). While the ARA coverage is contemplated.
